showed a trendP = 0.07
Compared to Gly placebo, the Gln group showed a trend toward a reduction in the mean mucositis score (Gln: 3.0 ± 0.3 versus Gly: 3.9 ± 0.4, P = 0.07) as well as a reduction in the number of d of IV narcotics use (12.1 ± 1.5 d versus Gly: 19.3 ± 2.8 d, P < 0.05) and TPN (17.3 ± 1.7 d versus Gly: 27.3 ± 3.6 d, P = 0.01).